Alnylam Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Alnylam Pharmaceuticals patents 222 in total

Status Patent
Grant
Utility: Polynucleotide agents targeting hydroxyacid oxidase (glycolate oxidase, HAO1) and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: Serpina1 siRNAs: compositions of matter and methods of treatment External link
Filling date: 8 Sep 2025 Issue date: 2 Mar 2021
Grant
Utility: Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 2 Mar 2021
Grant
Utility: Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 2 Mar 2021
Grant
Utility: Myostatin iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 2 Mar 2021
Application
Utility: ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 18 Feb 2021
Grant
Utility: Serpina1 iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 16 Feb 2021
Application
Utility: SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT External link
Filling date: 8 Sep 2025 Issue date: 11 Feb 2021
Grant
Utility: TMPRSS6 iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 9 Feb 2021
Application
Utility: MODIFIED DOUBLE-STRANDED RNA AGENTS External link
Filling date: 8 Sep 2025 Issue date: 21 Jan 2021
Grant
Utility: Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 12 Jan 2021
Application
Utility: STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 7 Jan 2021
Grant
Utility: Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 5 Jan 2021
Application
Utility: TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES External link
Filling date: 8 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE External link
Filling date: 8 Sep 2025 Issue date: 3 Dec 2020
Grant
Utility: Methods and compositions for treating a proprotein convertase subtilisin kexin (PCSK9) gene-associated disorder External link
Filling date: 8 Sep 2025 Issue date: 1 Dec 2020
Grant
Utility: Glucokinase (GCK) iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 24 Nov 2020
Application
Utility: MODIFIED RNAi AGENTS External link
Filling date: 8 Sep 2025 Issue date: 12 Nov 2020
Grant
Utility: TMPRSS6 iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 10 Nov 2020
Application
Utility: SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENT COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: ASSAYS AND METHODS FOR DETERMINING EXPRESSION OF THE LECT2 GENE External link
Filling date: 8 Sep 2025 Issue date: 29 Oct 2020
Grant
Utility: Angiotensinogen (AGT) iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 27 Oct 2020
Application
Utility: Dual Targeting siRNA Agents External link
Filling date: 8 Sep 2025 Issue date: 22 Oct 2020
Grant
Utility: Carbohydrate conjugates as delivery agents for oligonucleotides External link
Filling date: 8 Sep 2025 Issue date: 20 Oct 2020
Grant
Utility: Oligonucleotide-ligand conjugates and process for their preparation External link
Filling date: 8 Sep 2025 Issue date: 20 Oct 2020
Application
Utility: RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: Compositions and Methods for Inhibiting Expression of the PCSK9 Gene External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: HIGH MOBILITY GROUP BOX-1 (HMGB1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES External link
Filling date: 8 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: METHODS AND COMPOSITIONS FOR DETECTING ANTI-DRUG ANTIBODIES External link
Filling date: 8 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: Compositions and Methods for Inhibiting Expression of Transthyretin External link
Filling date: 8 Sep 2025 Issue date: 10 Sep 2020
Grant
Utility: Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 8 Sep 2020
Application
Utility: INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes External link
Filling date: 8 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 20 Aug 2020
Grant
Utility: Compositions and methods for inhibiting expression of CD274/PD-L1 gene External link
Filling date: 8 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Compositions and methods for inhibiting expression of the LECT2 gene External link
Filling date: 8 Sep 2025 Issue date: 18 Aug 2020
Application
Utility: THERAPEUTIC COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: POLYNUCLEOTIDE AGENTS TARGETING PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITIION OF EXPRESSION OF PROTEIN C (PROC) GENES External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF SERUM AMYLOID A GENE External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V External link
Filling date: 8 Sep 2025 Issue date: 23 Jul 2020

Showing 100 to 150 of 222 patents.